Pharmacologic management of constipation in the critically ill patient

被引:36
作者
Patanwala, Asad E.
Abarca, Jacob
Huckleberry, Yvonne
Erstad, Brian L.
机构
[1] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA
[2] Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharmacoEcon Res, Tucson, AZ 85721 USA
来源
PHARMACOTHERAPY | 2006年 / 26卷 / 07期
关键词
constipation; bowel movement; medical intensive care unit; critically ill patient; opioid; stimulant laxative; osmotic laxative;
D O I
10.1592/phco.26.7.896
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To compare the effectiveness of common laxatives in producing a bowel movement in patients admitted to a medical intensive care unit (MICU). Design. Retrospective medical record review. Setting. MICU of an academic medical center. Patients. Ninety-five patients admitted to the MICU from July 1-October 3 1, 2004. Measurements and Main Results. Fifty patients satisfied the inclusion criteria. Patient-specific data such as age, weight, sex, length of MICU stay, Acute Physiology and Chronic Health Evaluation (APACHE) 11 score, dietary intake, opioid intake, laxative intake, and bowel movements were recorded during the first 96 hours of admission. Logistic regression analysis was used to compare patients who did and did not have a bowel movement. Of the 50 patients, 25 did not have a bowel movement during the first 96 hours of MICU admission. Patients given a stimulant laxative (senna, bisacodyl) and/or an osmotic laxative (lactulose, milk of magnesia) were more likely to have a bowel movement (odds ratio [OR] 26.6, 95% confidence interval [CI] 3.2-221, p=0.002). Opioid intake, expressed as logarithmic morphine equivalents, was negatively associated with occurrence of a bowel movement (OR 0.76, 95% CI 0.59-0.97, p=0.027). Disease severity, as determined by APACHE 11 score, was also negatively associated with a bowel movement (OR 0.84, 95% CI 0.7-0.99, p=0.04). Conclusion. Critically ill patients have a high frequency of constipation, and opioid therapy is a significant risk factor. Routine administration of stimulant or osmotic laxatives should be considered for this patient population.
引用
收藏
页码:896 / 902
页数:7
相关论文
共 15 条
[1]   Laxative prescribing in relation to opioid use and the influence of pharmacy-based intervention [J].
Bouvy, ML ;
Buurma, H ;
Egberts, TCG .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (02) :107-110
[2]  
CAMERON JC, 1992, CANCER NURS, V15, P372
[3]   Management of opioid-induced gastrointestinal effects in patients receiving palliative care [J].
Herndon, CM ;
Jackson, KC ;
Hallin, PA .
PHARMACOTHERAPY, 2002, 22 (02) :240-250
[4]  
Hill S, 1998, Nurs Crit Care, V3, P134
[5]   How useful is docusate in patients at risk for constipation? A systematic review of the evidence in the chronically ill [J].
Hurdon, V ;
Viola, R ;
Schroder, C .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (02) :130-136
[6]   Epidemiology and natural history of primary biliary cirrhosis in a US community [J].
Kim, WR ;
Lindor, KD ;
Locke, GR ;
Therneau, TM ;
Homburger, HA ;
Batts, KP ;
Yawn, BP ;
Petz, JL ;
Melton, LJ ;
Dickson, ER .
GASTROENTEROLOGY, 2000, 119 (06) :1631-1636
[7]   Opioid-induced bowel dysfunction - Pathophysiology and potential new therapies [J].
Kurz, A ;
Sessler, DI .
DRUGS, 2003, 63 (07) :649-671
[8]   Current concepts: Chronic constipation [J].
Lembo, A ;
Camilleri, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1360-1368
[9]   Constipation and its implications in the critically ill patient [J].
Mostafa, SM ;
Bhandari, S ;
Ritchie, G ;
Gratton, N ;
Wenstone, R .
BRITISH JOURNAL OF ANAESTHESIA, 2003, 91 (06) :815-819
[10]   Myths and misconceptions about chronic constipation [J].
Müller-Lissner, SA ;
Kamm, MA ;
Scarpignato, C ;
Wald, A .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) :232-242